Insider Urges: Get Out Of Cash Before April 27th
Chris Rowe says there’s a huge stock market event looming - and he’s revealing his #1 pick for free.
Click here to find out more.
pixel

VRTX Insider Trading (Vertex Pharmaceuticals)

Insider Ownership Percentage: 0.70%
Insider Buying (Last 12 Months): $3,260,400.00
Insider Selling (Last 12 Months): $90,911,898.88

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

$213.35
▲ +3.07 (1.46%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
April 30th is approaching, are you prepared?
A new president’s policies always influence key stocks.
Here’s where top billionaires are investing.
pixel

Vertex Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/5/2021Bastiano SannaEVPSell1,686$214.14$361,040.0436,223  
2/11/2021Bastiano SannaEVPSell1,686$210.56$355,004.1639,081  
2/11/2021Paul M SilvaCAOSell1,498$210.57$315,433.8624,073  
2/5/2021Michael PariniEVPSell1,930$215.00$414,950.0059,157  
2/3/2021Michael PariniEVPSell400$216.56$86,624.0035,276  
11/10/2020Bruce I SachsDirectorBuy15,000$217.36$3,260,400.0018,035  
11/3/2020Stuart A ArbuckleEVPSell1,553$211.92$329,111.7636,732  
10/5/2020Sangeeta N BhatiaDirectorSell10,516$266.79$2,805,563.6414,424  
8/3/2020Amit SachdevEVPSell1,941$278.28$540,141.4837,044  
7/13/2020Michael PariniEVPSell2,125$292.05$620,606.2528,963  
7/13/2020Paul M SilvaSVPSell860$292.03$251,145.8015,792  
7/10/2020Charles F Wagner JrCFOSell700$293.15$205,205.0016,786  
7/7/2020Stuart A ArbuckleEVPSell2,786$300.00$835,800.0036,743  
6/30/2020Jeffrey M LeidenChairmanSell32,792$286.15$9,383,430.8029,252  
5/12/2020Jeffrey M LeidenChairmanSell94,370$283.47$26,751,063.9065,036  
5/11/2020Amit SachdevEVPSell10,665$282.61$3,014,035.6545,768  
5/7/2020Bruce I SachsDirectorSell45,000$269.80$12,141,000.0033,710  
5/6/2020Paul M SilvaSVPSell1,076$272.74$293,468.2415,397  
5/5/2020Amit SachdevEVPSell13,356$270.01$3,606,253.5667,603  
5/5/2020Jeffrey M LeidenChairmanSell94,372$269.94$25,474,777.6876,707  
5/4/2020Paul M SilvaSVPSell809$260.87$211,043.8315,741  
4/29/2020Michael PariniEVPSell2,125$254.95$541,768.7528,963  
4/27/2020Yuchun LeeDirectorSell2,000$271.21$542,420.003,875  
4/24/2020Yuchun LeeDirectorSell2,000$268.14$536,280.003,875  
4/22/2020Yuchun LeeDirectorSell2,000$267.88$535,760.003,875  
4/20/2020Yuchun LeeDirectorSell2,000$273.16$546,320.003,875  
4/13/2020Paul M SilvaSVPSell859$248.72$213,650.4815,791  
4/6/2020Paul M SilvaSVPSell4,891$255.57$1,249,992.8719,823  
2/25/2020Amit SachdevEVPSell3,376$233.53$788,397.2836,291  
2/25/2020Jeffrey M LeidenCEOSell10,550$233.46$2,463,003.00103,131  
2/25/2020Ourania TatsisSVPSell1,296$233.17$302,188.3214,034  
2/25/2020Reshma KewalramaniCMOSell3,634$233.45$848,357.3030,260  
2/18/2020Amit SachdevEVPSell3,489$243.56$849,780.8442,936  
2/18/2020Jeffrey M LeidenCEOSell11,685$243.52$2,845,531.20123,226  
2/18/2020Ourania TatsisSVPSell1,279$243.62$311,589.9816,349  
2/18/2020Reshma KewalramaniCMOSell1,183$243.51$288,072.3334,341  
2/7/2020Yuchun LeeDirectorSell2,000$237.82$475,640.003,875  
2/4/2020Yuchun LeeDirectorSell2,000$238.84$477,680.003,875  
1/22/2020Michael PariniEVPSell1$237.50$237.5035,004  
1/16/2020Amit SachdevEVPSell5,000$235.00$1,175,000.0041,190  
1/13/2020Michael PariniEVPSell2,125$226.78$481,907.5037,128  
1/13/2020Paul M SilvaSVPSell860$229.38$197,266.8018,619  
1/8/2020Amit SachdevEVPSell5,000$230.00$1,150,000.0041,190  
1/8/2020Paul M SilvaSVPSell13,750$231.89$3,188,487.5031,509  
1/6/2020Michael PariniEVPSell4,250$222.00$943,500.0039,253  
1/2/2020Paul M SilvaSVPSell25,630$218.92$5,610,919.6034,517  
1/2/2020William D YoungDirectorSell20,000$218.93$4,378,600.0029,311  
12/9/2019Amit SachdevEVPSell5,000$225.00$1,125,000.0038,416  
11/25/2019Amit SachdevEVPSell5,000$220.00$1,100,000.0038,416  
11/25/2019Reshma KewalramaniCMOSell4,692$219.37$1,029,284.0417,790  
11/19/2019Amit SachdevEVPSell5,000$215.00$1,075,000.0038,416  
11/18/2019Jeffrey M LeidenCEOSell9,434$216.75$2,044,819.50170,378  
11/13/2019Michael PariniEVPSell4,892$205.50$1,005,306.0039,895  
11/13/2019Ourania TatsisSVPSell2,853$205.59$586,548.2710,105  
11/8/2019Reshma KewalramaniCMOSell509$199.00$101,291.0013,607  
11/6/2019David AltshulerEVPSell1,223$197.21$241,187.8332,776  
11/4/2019Amit SachdevEVPSell4,097$200.34$820,792.9835,571  
11/1/2019Jeffrey M LeidenCEOSell96,822$200.02$19,366,336.44115,166  
11/1/2019Sangeeta N BhatiaDirectorSell1,291$200.00$258,200.006,540  
10/30/2019Reshma KewalramaniCMOSell3,057$199.00$608,343.0016,155  
10/25/2019Amit SachdevEVPSell4,311$197.89$853,103.7937,727  
10/22/2019Amit SachdevEVPSell3,883$190.27$738,818.4137,299  
10/22/2019Jeffrey M LeidenCEOSell107,831$190.00$20,487,890.00178,707  
10/22/2019Margaret G McglynnDirectorSell20,000$190.00$3,800,000.0024,124  
10/22/2019Reshma KewalramaniCMOSell638$189.00$120,582.0013,098  
10/17/2019Michael PariniEVPSell4,250$177.80$755,650.0039,253  
10/14/2019Michael PariniEVPSell2,125$174.06$369,877.5037,128  
10/2/2019Sangeeta N BhatiaDirectorSell8,379$166.80$1,397,617.207,810  
10/1/2019Ourania TatsisSVPSell188$169.11$31,792.687,696  
8/19/2019David AltshulerEVPSell12,501$186.38$2,329,936.3835,803  
8/13/2019Margaret G McglynnDirectorSell10,000$185.00$1,850,000.0014,124  
8/8/2019Stuart A ArbuckleEVPSell2,125$181.89$386,516.2535,365  
8/5/2019Michael PariniEVPSell2,330$175.28$408,402.4034,395  
8/2/2019Stuart A ArbuckleEVPSell2,155$177.78$383,115.9034,395  
7/12/2019Michael PariniEVPSell2,125$175.27$372,448.7537,128  
7/5/2019Michael PariniEVPSell4,250$179.11$761,217.5039,253  
6/19/2019Stuart A ArbuckleEVPSell2,125$181.89$386,516.2535,365  
6/18/2019Jeffrey M LeidenCEOSell56,030$175.39$9,827,101.70162,317  
6/3/2019Sangeeta N BhatiaDirectorSell720$167.08$120,297.607,260  
5/24/2019Jeffrey M LeidenCEOSell113,432$175.10$19,861,943.20219,719  
5/15/2019Amit SachdevEVPSell61$165.41$10,090.0133,416  
5/15/2019Paul M SilvaSVPSell161$165.41$26,631.0117,759  
5/15/2019Reshma KewalramaniCMOSell241$165.41$39,863.8113,736  
5/6/2019Jeffrey M LeidenCEOSell33,058$175.01$5,785,480.58136,953  
5/3/2019Michael PariniEVPSell1,622$172.06$279,081.3237,332  
5/1/2019Jeffrey M LeidenCEOSell10,480$175.08$1,834,838.40  
4/15/2019Stuart A ArbuckleEVPSell5,624$181.75$1,022,162.0036,272  
2/19/2019David AltshulerEVPSell5,624$187.00$1,051,688.0032,604  
2/19/2019Jeffrey M LeidenCEOSell20,997$186.98$3,926,019.06110,095  
2/19/2019Paul M SilvaSVPSell2,812$186.97$525,759.6418,903  
2/19/2019Reshma KewalramaniCMOSell1,488$186.94$278,166.7214,038  
2/11/2019Jeffrey M LeidenCEOSell111,431$180.24$20,084,323.44223,916  
2/11/2019Michael PariniEVPSell12,136$180.22$2,187,149.9260,050  
2/11/2019Paul M SilvaSVPSell4,215$180.16$759,374.4023,386  
2/6/2019Paul M SilvaSVPSell1,289$193.00$248,777.0013,938  
2/4/2019Jeffrey M LeidenCEOSell32,250$186.35$6,009,787.50155,815  
2/4/2019Michael PariniEVPSell2,330$189.19$440,812.7038,489  
2/4/2019Paul M SilvaSVPSell4,247$187.02$794,273.9416,896  
2/1/2019Michael PariniEVPSell3,450$190.92$658,674.00  
1/22/2019David AltshulerEVPSell2,125$193.48$411,145.0041,238  
1/18/2019David AltshulerEVPSell1,223$194.62$238,020.2640,336  
1/17/2019Paul M SilvaSVPSell3,007$190.62$573,194.3417,376  
1/14/2019Michael PariniEVPSell2,125$186.71$396,758.7541,734  
1/4/2019Michael PariniEVPSell4,250$165.90$705,075.0043,859  
12/3/2018Paul M SilvaSVPSell809$186.52$150,894.6816,896  
11/15/2018David AltshulerEVPSell100$163.75$16,375.00  
11/15/2018Paul M SilvaSVPSell12$163.75$1,965.0016,087  
11/7/2018David AltshulerEVPSell2,125$181.89$386,516.2548,877  
11/5/2018David AltshulerEVPSell4,126$173.51$715,902.2640,909  
11/2/2018Stuart A ArbuckleEVPSell2,155$175.36$377,900.8048,907  
10/12/2018Michael PariniEVPSell2,125$177.20$376,550.0041,734  
10/8/2018Reshma KewalramaniCMOSell2,305$186.95$430,919.751,909  
10/4/2018Michael PariniEVPSell4,250$191.58$814,215.0043,859  
10/3/2018Sangeeta N BhatiaDirectorSell6,818$192.13$1,309,942.346,997  
10/1/2018David AltshulerEVPSell2,445$194.62$475,845.90  
10/1/2018Thomas GraneyCFOSell1,076$193.24$207,926.24  
8/28/2018David AltshulerEVPSell2,125$181.89$386,516.2541,238  
8/3/2018Paul M SilvaSVPSell2,098$174.44$365,975.1217,376  
8/3/2018Stuart A ArbuckleEVPSell10,083$175.29$1,767,449.0748,877  
7/16/2018Paul M SilvaSVPSell860$179.85$154,671.0016,947  
7/16/2018Stuart A ArbuckleEVPSell8,500$179.21$1,523,285.0053,127  
7/12/2018Michael PariniEVPSell2,125$175.02$371,917.5041,734  
7/12/2018Paul M SilvaSVPSell860$175.02$150,517.2016,947  
7/5/2018Michael PariniEVPSell4,250$168.38$715,615.0043,859  
6/29/2018Amit SachdevEVPSell4,096$167.63$686,612.4848,603  
6/29/2018Ian F SmithCOOSell23,375$166.30$3,887,262.5070,074  
6/29/2018Paul M SilvaSVPSell2,957$166.52$492,399.6416,946  
6/22/2018Ian F SmithCOOSell4,250$160.00$680,000.0050,949  
6/22/2018Jeffrey M LeidenCEOSell140,211$160.00$22,433,760.00297,260  
6/4/2018Sangeeta N BhatiaDirectorSell875$152.05$133,043.755,754  
5/15/2018Ian F SmithCOOSell217$155.78$33,804.2646,699  
5/15/2018Paul M SilvaSVPSell201$155.78$31,311.7816,087  
5/15/2018Stuart A ArbuckleEVPSell138$155.78$21,497.6446,662  
5/11/2018Ian F SmithCOOSell4,096$155.00$634,880.00  
5/3/2018Michael PariniEVPSell2,330$149.50$348,335.0041,939  
4/26/2018Ian F SmithCOOSell85,093$158.32$13,471,923.7668,745  
4/26/2018Michael PariniEVPSell40,764$159.29$6,493,297.5642,123  
4/18/2018Paul M SilvaSVPSell859$166.05$142,636.9516,946  
4/16/2018Stuart A ArbuckleEVPSell2,125$163.01$346,396.2548,877  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

92.17% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/9/2021EFG Asset Management Americas Corp.1,582$0.34M0.1%+22.9%0.001%
4/9/2021Ipswich Investment Management Co. Inc.6,320$1.36M0.4%N/A0.002%
4/9/2021State of Alaska Department of Revenue40,729$8.75M0.1%-4.3%0.016%
4/9/2021Selective Wealth Management Inc.150$32K0.0%+50.0%0.000%
4/9/2021NuWave Investment Management LLC1,352$0.29M0.4%N/A0.001%
4/6/2021UMA Financial Services Inc.967$0.21M0.1%N/A0.000%
4/6/2021Chesley Taft & Associates LLC3,814$0.82M0.0%-54.5%0.001%
4/6/2021Carroll Financial Associates Inc.414$88K0.0%+13.1%0.000%
4/6/2021LVM Capital Management Ltd. MI29,185$6.27M1.0%+1.4%0.011%
4/6/2021Everence Capital Management Inc.5,704$1.23M0.1%N/A0.002%
4/5/2021Pacer Advisors Inc.24,123$5.18M0.1%-8.1%0.009%
4/5/2021Woodstock Corp4,289$0.92M0.1%-14.5%0.002%
3/31/2021SWS Partners3,785$0.90M0.4%+37.4%0.001%
3/30/2021Koshinski Asset Management Inc.2,428$0.57M0.1%+16.3%0.001%
3/24/2021Alpha DNA Investment Management LLC271$64K0.1%N/A0.000%
3/12/2021DekaBank Deutsche Girozentrale234,495$54.69M0.2%-8.2%0.090%
3/9/2021Defined Wealth Management LLC880$0.21M0.2%N/A0.000%
3/9/2021Childress Capital Advisors LLC315$74K0.0%N/A0.000%
3/9/2021Amundi Pioneer Asset Management Inc.817,089$193.11M0.2%+87.9%0.314%
3/9/2021Tealwood Asset Management Inc.6,035$1.43M0.7%+69.1%0.002%
3/8/2021B. Metzler seel. Sohn & Co. Holding AG16,789$3.92M0.1%N/A0.006%
3/8/2021Teachers Retirement System of The State of Kentucky129,010$30.49M0.3%-5.6%0.050%
3/8/2021Harvest Volatility Management LLC3,486$0.82M0.1%N/A0.001%
3/8/2021Dimensional Fund Advisors LP454,549$107.42M0.0%+4.4%0.175%
3/5/2021Voya Financial Advisors Inc.903$0.21M0.0%-18.1%0.000%
3/4/2021Hudson Bay Capital Management LP30,000$7.09M0.1%+200.0%0.012%
3/4/2021Moody National Bank Trust Division29,766$7.04M0.2%+0.4%0.011%
3/2/2021SkyView Investment Advisors LLC1,303$0.31M0.1%N/A0.001%
3/2/2021Norges Bank2,771,326$654.98M0.2%N/A1.066%
3/2/2021Capital Asset Advisory Services LLC456$0.11M0.0%N/A0.000%
3/2/2021Livforsakringsbolaget Skandia Omsesidigt14,287$3.38M0.3%+26.6%0.005%
3/1/2021UBS Asset Management Americas Inc.2,087,167$493.28M0.2%+29.3%0.803%
3/1/2021Healthcare of Ontario Pension Plan Trust Fund85,198$20.14M0.1%+258,075.8%0.033%
3/1/2021Main Street Financial Solutions LLC1,514$0.36M0.1%N/A0.001%
2/26/2021Avitas Wealth Management LLC5,076$1.20M0.2%+24.2%0.002%
2/26/2021Doheny Asset Management CA1,375$0.33M0.2%N/A0.001%
2/25/2021Dimensional Fund Advisors LP454,549$107.42M0.0%+4.4%0.175%
2/24/2021Broadleaf Partners LLC30,885$7.30M2.9%+0.2%0.012%
2/24/2021Bank Julius Baer & Co. Ltd Zurich16,248$3.84M0.0%+93.5%0.006%
2/23/2021Principal Financial Group Inc.348,629$82.40M0.1%-5.1%0.134%
2/19/2021JPMorgan Chase & Co.2,588,024$611.65M0.1%+15.5%0.996%
2/19/2021AtonRa Partners11,560$2.73M1.3%N/A0.004%
2/19/2021Berman Capital Advisors LLC354$83K0.0%-17.3%0.000%
2/19/2021International Biotechnology Trust PLC97,322$22.98M6.3%+50.1%0.037%
2/19/2021Rehmann Capital Advisory Group1,824$0.43M0.0%-10.1%0.001%
2/19/2021National Pension Service354,093$83.69M0.2%+6.6%0.136%
2/18/2021Verition Fund Management LLC884$0.21M0.0%-23.3%0.000%
2/18/2021Strategic Wealth Partners Ltd.1,027$0.24M0.1%N/A0.000%
2/18/2021Symmetry Partners LLC1,877$0.44M0.0%-4.0%0.001%
2/18/2021Truist Financial Corp39,521$9.34M0.0%-6.4%0.015%
2/17/2021Voloridge Investment Management LLC260,785$61.63M0.5%+297.5%0.100%
2/17/2021IHT Wealth Management LLC5,072$1.20M0.1%+91.9%0.002%
2/17/2021Castleark Management LLC730$0.17M0.0%-21.5%0.000%
2/17/2021United Capital Financial Advisers LLC3,035$0.72M0.0%-87.5%0.001%
2/17/2021Cim Investment Mangement Inc.1,772$0.42M0.1%N/A0.001%
2/17/2021Baker Avenue Asset Management LP2,238$0.53M0.0%-61.2%0.001%
2/17/2021Canada Pension Plan Investment Board53,298$12.60M0.0%-23.0%0.020%
2/17/2021Advisor Partners LLC6,878$1.63M0.1%-9.6%0.003%
2/17/2021Prestige Wealth Management Group LLC148$35K0.0%-27.8%0.000%
2/17/2021Cetera Investment Advisers17,201$4.07M0.1%+241.0%0.007%
2/17/2021Cetera Advisors LLC4,843$1.15M0.0%+15.3%0.002%
2/17/2021Kiwi Wealth Investments Limited Partnership23,460$5.55M0.3%+849.0%0.009%
2/16/2021Orbimed Advisors LLC834,100$197.13M1.7%+25.2%0.321%
2/16/2021Zacks Investment Management28,747$6.79M0.1%-22.6%0.011%
2/16/2021Tokio Marine Asset Management Co. Ltd.1,747$0.41M0.0%+10.2%0.001%
2/16/2021Silverarc Capital Management LLC5,000$1.18M0.7%N/A0.002%
2/16/2021Squarepoint Ops LLC6,840$1.62M0.0%-89.5%0.003%
2/16/2021Mcdonald Partners LLC1,673$0.40M0.1%N/A0.001%
2/16/2021Headinvest LLC1,033$0.24M0.0%N/A0.000%
2/16/2021Glenmede Trust Co. NA65,617$15.51M0.1%+1,693.3%0.025%
2/16/2021Morgan Stanley917,848$216.92M0.0%+18.7%0.353%
2/16/2021Cozad Asset Management Inc.3,930$0.93M0.2%+12.0%0.002%
2/16/2021Principal Street Partners LLC4,434$1.05M0.3%+5.4%0.002%
2/16/2021Toroso Investments LLC2,055$0.49M0.0%+41.9%0.001%
2/16/2021Paloma Partners Management Co12,030$2.84M0.1%+447.6%0.005%
2/16/2021LMR Partners LLP15,989$3.78M0.1%+529.0%0.006%
2/16/2021Tudor Investment Corp Et Al46,303$10.94M0.3%+711.9%0.018%
2/16/2021Knights of Columbus Asset Advisors LLC11,651$2.75M0.3%-22.0%0.004%
2/16/2021Nuveen Asset Management LLC2,637,754$623.41M0.2%-24.7%1.014%
2/16/2021Davidson Kempner Capital Management LP44,600$10.53M0.2%N/A0.017%
2/16/2021Captrust Financial Advisors1,673$0.40M0.0%-63.7%0.001%
2/16/2021Colony Group LLC1,421$0.34M0.0%-40.9%0.001%
2/16/2021Guggenheim Capital LLC209,790$49.58M0.3%+9.2%0.081%
2/16/2021Price T Rowe Associates Inc. MD19,626,924$4.63B0.5%-3.7%7.548%
2/16/2021Kingsview Wealth Management LLC3,715$0.88M0.1%+52.6%0.001%
2/16/2021Amundi Pioneer Asset Management Inc.817,089$193.11M0.2%+87.9%0.314%
2/16/2021Alpha DNA Investment Management LLC249$58K0.1%N/A0.000%
2/16/2021Virginia Retirement Systems ET AL119,200$28.17M0.3%+66.0%0.046%
2/16/2021New York Life Investments Alternatives1,792$0.42M0.3%N/A0.001%
2/16/2021ETF Managers Group LLC1,164$0.27M0.0%-55.6%0.000%
2/16/2021Schroder Investment Management Group25,559$6.04M0.0%-5.5%0.010%
2/16/2021Engineers Gate Manager LP2,579$0.61M0.0%-78.2%0.001%
2/16/2021Ashford Capital Management Inc.5,709$1.35M0.1%+4.0%0.002%
2/16/2021Avidity Partners Management LP147,300$34.81M1.1%N/A0.057%
2/16/2021Janus Henderson Group PLC4,166,534$984.70M0.5%+119.2%1.602%
2/16/2021A.R.T. Advisors LLC2,824$0.67M3.1%N/A0.001%
2/16/2021ExodusPoint Capital Management LP18,913$4.47M0.0%+177.2%0.007%
2/16/2021Benjamin F. Edwards & Company Inc.3,400$0.80M0.0%+3.6%0.001%
2/16/2021Capital International Ltd.81,159$19.18M1.1%-1.3%0.031%
2/16/2021Parametrica Management Ltd923$0.22M0.1%N/A0.000%
Data available starting January 2016

See Full Table
Vertex Pharmaceuticals logo
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. Its pipeline includes Pipeline for Alpha-1 antitrypsin deficiency that is in Phase 2 clinical trial; VX-864, a second investigational small molecule corrector for the treatment of AAT deficiency, which is in Phase 1 clinical trial; and VX-147 that completed a Phase 1 clinical trial for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG; Arbor Biotechnologies, Inc.; Moderna, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany; X-Chem, Inc.; Janssen Pharmaceuticals, Inc.; Merck KGaA; Kymera Therapeutics; Ribometrix, Inc.; Molecular Templates, Inc.; and Affinia Therapeutics. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $213.35
$209.53
$213.82

50 Day Range

MA: $213.45
$207.02
$219.65

52 Week Range

Now: $213.35
$202.57
$306.08

Volume

1,519,333 shs

Average Volume

2,072,177 shs

Market Capitalization

$55.46 billion

P/E Ratio

26.94

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?

Vertex Pharmaceuticals' top insider shareholders include:
  1. Jeffrey M Leiden (CEO)
  2. Jeffrey M Leiden (Chairman)
  3. Amit Sachdev (EVP)
  4. Michael Parini (EVP)
  5. Bastiano Sanna (EVP)
  6. Stuart A Arbuckle (EVP)
  7. David Altshuler (EVP)
  8. Paul M Silva (SVP)
  9. Reshma Kewalramani (CMO)
  10. Bruce I Sachs (Director)
  11. William D Young (Director)
  12. Margaret G Mcglynn (Director)
  13. Paul M Silva (CAO)
  14. Charles F Wagner Jr (CFO)
  15. Ourania Tatsis (SVP)
  16. Sangeeta N Bhatia (Director)
  17. Yuchun Lee (Director)

Who are the major institutional investors of Vertex Pharmaceuticals?

Vertex Pharmaceuticals' top institutional investors include:
  1. State of Alaska Department of Revenue — 0.02%
  2. LVM Capital Management Ltd. MI — 0.01%
  3. Pacer Advisors Inc. — 0.01%
  4. Ipswich Investment Management Co. Inc. — 0.00%
  5. Everence Capital Management Inc. — 0.00%
  6. Woodstock Corp — 0.00%

Which major investors are selling Vertex Pharmaceuticals stock?

Within the previous quarter, VRTX stock was sold by these institutional investors:
  1. Chesley Taft & Associates LLC
  2. Pacer Advisors Inc.
  3. State of Alaska Department of Revenue
  4. Woodstock Corp
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
  1. Jeffrey M Leiden (CEO)
  2. Jeffrey M Leiden (Chairman)
  3. Amit Sachdev (EVP)
  4. Michael Parini (EVP)
  5. Bastiano Sanna (EVP)
  6. Stuart A Arbuckle (EVP)
  7. David Altshuler (EVP)
  8. Paul M Silva (SVP)
  9. Reshma Kewalramani (CMO)
  10. Bruce I Sachs (Director)
  11. William D Young (Director)

Which major investors are buying Vertex Pharmaceuticals stock?

During the previous quarter, VRTX stock was acquired by institutional investors including:
  1. Ipswich Investment Management Co. Inc.
  2. Everence Capital Management Inc.
  3. NuWave Investment Management LLC
  4. UMA Financial Services Inc.
  5. LVM Capital Management Ltd. MI
  6. EFG Asset Management Americas Corp.
  7. Selective Wealth Management Inc.
  8. Carroll Financial Associates Inc.
Insider Urges: Get Out Of Cash Before April 27th
Chris Rowe says there’s a huge stock market event looming - and he’s revealing his #1 pick for free.
Click here to find out more.
pixel